Cargando…
Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
INTRODUCTION: Pharmacological therapy is recommended as a second-line alternative to reverse obesity. Currently, five anti-obesity drugs (AODs) have been approved by the U.S. Food and Drug Administration (FDA) for chronic weight management. The aim of this paper is to investigate the pharmacoeconomi...
Autores principales: | Xue, Yan, Zou, Huimin, Ruan, Zhen, Chen, Xianwen, Lai, Yunfeng, Yao, Dongning, Ung, Carolina Oi Lam, Hu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658190/ https://www.ncbi.nlm.nih.gov/pubmed/38027186 http://dx.doi.org/10.3389/fendo.2023.1254398 |
Ejemplares similares
-
Comparative analysis of disease modelling for health economic evaluations of systemic therapies in advanced hepatocellular carcinoma
por: Zou, Huimin, et al.
Publicado: (2023) -
Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
por: Luo, Zejun, et al.
Publicado: (2021) -
Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research
por: Xue, Yan, et al.
Publicado: (2023) -
Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
por: Zou, Huimin, et al.
Publicado: (2022) -
Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis
por: Zou, Huimin, et al.
Publicado: (2022)